CJ
Chinmay Jani
Research areas: Medicine · Oncology · Global Cancer Incidence and Screening · Lung Cancer Diagnosis and Treatment · COVID-19 Clinical Research Studies
0000-0002-6917-5568
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
-
Phase 2 Study of Clostridium butyricum strain CBM588 Probiotic and Inulin to Enhance Immunotherapy Outcomes in Non-Small Cell Lung Cancer Binaytara Foundation2026 - 2028
Publications (280)
- Amivantamab-vmjw and Cutaneous Toxicity: A Practical Approach to Management Save
- Alcohol-attributable cancer mortality in the United States, 1990–2023: a secondary analysis of Global Burden of Disease data Save
- Liquid biopsy biomarkers for cancer detection, treatment monitoring, and clinical outcome prediction. Save
- Data from Characterizing Longitudinal Molecular Changes in ctDNA in Patients with Metastatic Castration-Resistant Prostate Cancer Save
- Supplementary Data from Characterizing Longitudinal Molecular Changes in ctDNA in Patients with Metastatic Castration-Resistant Prostate Cancer Save
- Tarlatamab in Previously Treated Small Cell Lung Cancer: A Real-World Experience in a Predominantly Hispanic Population with CNS Metastases Save
- Geographic, Temporal, and Sex-Specific Trends in Mesothelioma Burden in the United States, 1990–2023 Save
- Triple M Overlap Syndrome After Immune Checkpoint Inhibitors: A Case Series of a High-Mortality Phenotype. Save
- Concurrent tissue and circulating tumor DNA analysis in renal cell carcinoma: insights from a multimodal database Save
- Characterizing Longitudinal Molecular Changes in ctDNA in Patients with Metastatic Castration-resistant Prostate Cancer Save
- A phase 1 trial of the oncolytic virus SVV-001 in combination with nivolumab and ipilimumab in patients with poorly differentiated neuroendocrine carcinomas or well-differentiated grade 3 neuroendocrine tumors Save
- A phase 1 trial of the oncolytic virus SVV-001 with nivolumab and ipilimumab in patients with high-grade neuroendocrine neoplasms. Save
- An indirect comparison of EGFR TKI combination therapies in advanced EGFR-mutated NSCLC: Comparing manual and AI-generated analyses. Save
- Anti-PD-(L)1 plus chemotherapy in advanced PD-L1-negative nonsquamous non-small cell lung cancer: a systematic review and meta-analysis Save
- Burden of Central Nervous System Cancer in the United States, 1990-2021 Save
- Changing Epidemiology of Lung Cancer in the AYA Population: A Global and US Perspective on Incidence, Mortality, and Risk Factors Save
- Early-onset prostate cancer: A time series analysis of age-stratified trends. Save
- Efficacy without compromising resection: surgical outcomes from AEGEAN Save
- Evaluating AI decision support in a rapidly evolving therapeutic landscape: EGFR-mutant metastatic NSCLC Save
- Global lung cancer burden attributable to environmental and occupational exposures. Save